Blog Comments

Kinetica Online is pleased to provide direct links to commentaries from our senior editor Dr. Steven Pelech has posted on other blogs sites. Most of these comments appear on the GenomeWeb Daily Scan website, which in turn highlight interesting blogs that have been posted at numerous sites in the blogosphere since the beginning of 2010. A wide variety of topical subjects are covered ranging from the latest scientific breakthroughs, research trends, politics and career advice. The original blogs and Dr. Pelech’s comments are summarized here under the title of the original blog. Should viewers wish to add to these discussions, they should add their comments at the original blog sites.

The views expressed by Dr. Pelech do not necessarily reflect those of the other management and staff at Kinexus Bioinformatics Corporation. However, we wish to encourage healthy debate that might spur improvements in how biomedical research is supported and conducted.

Taking the Conflict-of-Interest Heat

Submitted by S. Pelech - Kinexus on Wed, 08/04/2010 - 14:24.
There seems to be relatively little concern when faculty in engineering departments provide consulting to industry or clinical scientists see patients to derive extra income. However, it seems like a huge sacrilege for faculty members in life sciences departments to consult with biotech companies and large pharma for a fee. The salaries of university faculty in the life sciences are relatively low compared to other professions with comparable educational and experience requirements. Moreover, tenure is becoming increasingly rare for those in the academic stream. One of the greatest disappointments to governments is the poor translation of basic research in the universities to practical applications that foster economic development. This is extremely critical for the survival of the economies of developed countries in the competitive flat world landscape. Working with industry provides academics the opportunities to apply their talents to tackling important problems such as diagnosing and curing diseases. We should be encouraging greater academic-industrial interactions, not actively discouraging them.

Link to the original blog post.